A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

NCT02362958 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

OTHER

Sponsor class

Conditions

HER2 Positive Breast Cancer

Interventions

DRUG: lapatinib and capecitabine or vinorelbine

Sponsor

Sun Yat-sen University